Submission of audited financial results for the quarter and financial year ended 3st March 2026
RESULTS
▼ Concern Flagged
HIGH RISK
📅 Filed on BSE: 27 May 2026, 07:52 PM IST · BSE ID: 90bc0577-225c-4fa0-b1de-17fb0d0cbdd0
View Original BSE Filing (PDF)
💡
In Simple Terms
The company released its full-year financial report, but its auditors flagged concerns about unpaid loan interest and how loans were handled.
🤖 AI Summary
- Johnson Pharmacare Ltd. filed audited financial results for FY26 and Q4 FY26.
- Statutory Auditors M/S V R S K & ASSOCIATES issued a qualified opinion on the results.
- Auditors cited non-provision of interest on loans and non-compliance with IND-AS.
- Balance of borrowed loans stood at Rs. 2140.04 Lakhs as of March 31, 2026.
- Fair valuation of unquoted instruments was a key audit matter due to unavailable independent reports.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Balance of borrowed loans as of March 31, 2026
Rs. 2140.04 Lakhs
🏢 How This Affects the Company
The qualified audit opinion and noted issues regarding loan interest provision could impact the reported financial performance and true state of affairs.
The qualified audit opinion and non-compliance with IND-AS introduce significant regulatory and financial reporting risk for the company.
👥 What This Means For Shareholders
✅
Action Required
Shareholders should review the audit report and management's response for clarity on the qualified opinion and noted financial matters.
👤
Who Is Affected
All shareholders are affected as the qualified opinion indicates potential inaccuracies in the reported financial position and performance for FY26.
🔍
Management Signal
Management submitted the results despite the qualified opinion, indicating adherence to regulatory disclosure timelines.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Company's response to the qualified audit opinion and identified issues.
Specific steps management plans to take regarding IND-AS compliance.
Details on the terms and status of the Rs. 2140.04 Lakhs in borrowed loans.
HIGH RISK
Qualified audit opinion, non-compliance with IND-AS, and significant concerns over borrowed loan accounting present high financial reporting risk.
💡 Investor Takeaway
Johnson Pharmacare Ltd.'s FY26 audited results received a qualified opinion from auditors. Key concerns included non-provision of interest on loans, a borrowed loan balance of Rs. 2140.04 Lakhs, and non-compliance with IND-AS.
⚖️ Strengths & Concerns
⚠️ Concerns
- Auditors issued a qualified opinion, stating financial statements 'may not give a true and fair view' due to non-provision of interest on loans.
- The company's balance of borrowed loans was Rs. 2140.04 Lakhs as of March 31, 2026, with audit concerns regarding terms and conversion to equity.
📅 Company Track Record
A past filing from 2026-05-27 also noted auditors issued a qualified opinion on Johnson Pharmacare's FY26 results, citing Rs. 2140.04 Lakhs in borrowed loans.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What is the key issue identified in Johnson Pharmacare's FY26 audit report?
The auditors issued a qualified opinion due to the non-provision of interest on loans, stating the financial statements may not give a true and fair view.
What was the balance of borrowed loans for Johnson Pharmacare as of March 31, 2026?
As of March 31, 2026, the company had a balance of borrowed loans amounting to Rs. 2140.04 Lakhs.
Did Johnson Pharmacare Ltd. comply with Indian Accounting Standards (IND-AS) for FY26?
The auditors noted that Johnson Pharmacare Ltd. should have prepared its financial statements in compliance with IND-AS, indicating non-compliance.
What was a key audit matter regarding investments for Johnson Pharmacare in FY26?
Fair valuation of investments in unquoted instruments was a key audit matter, with independent valuation reports reportedly unavailable for the auditors' consideration.
Questions based on this BSE filing only. For information purposes.